Cetera Investment Advisers 10x Genomics, Inc. Transaction History
Cetera Investment Advisers
- $80.6 Billion
- Q3 2025
A detailed history of Cetera Investment Advisers transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 27,456 shares of TXG stock, worth $436,275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,456
Previous 14,753
86.1%
Holding current value
$436,275
Previous $170,000
88.24%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TXG
# of Institutions
353Shares Held
118MCall Options Held
266KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA13.3MShares$211 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$189 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$102 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.44MShares$86.4 Million0.03% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.38MShares$85.5 Million0.04% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.51B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...